Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ovarian Neoplasms

  Free Subscription


Articles published in Curr Opin Obstet Gynecol

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    February 2024
  1. ALI M, Tewari KS
    A review of racial disparities in ovarian cancer and clinical trials.
    Curr Opin Obstet Gynecol. 2024;36:23-27.
    PubMed     Abstract available


  2. SALUTARI V, Giudice E, Lorusso D
    Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives.
    Curr Opin Obstet Gynecol. 2024;36:9-17.
    PubMed     Abstract available


    January 2024
  3. GARCIA-ILLESCAS D, Mazzeo R, Garcia-Duran C, Oaknin A, et al
    The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era.
    Curr Opin Obstet Gynecol. 2024 Jan 3. doi: 10.1097/GCO.0000000000000934.
    PubMed     Abstract available


    August 2023
  4. HABER HR, French HM, Movilla PR, Isaacson KB, et al
    Take it or leave it: oophorectomy at the time of benign hysterectomy.
    Curr Opin Obstet Gynecol. 2023;35:344-351.
    PubMed     Abstract available


    February 2023
  5. PRAISS AM, Moukarzel LA, Zivanovic O
    Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?
    Curr Opin Obstet Gynecol. 2023;35:21-26.
    PubMed     Abstract available


  6. TYMON-ROSARIO J, Gorman M, Richardson DL, Washington C, et al
    Advances in antibody-drug conjugates for gynecologic malignancies.
    Curr Opin Obstet Gynecol. 2023;35:6-14.
    PubMed     Abstract available


  7. QUESADA S, Bini M, Lebreton C, Ray-Coquard I, et al
    Update on new treatments for rare ovarian tumours.
    Curr Opin Obstet Gynecol. 2023;35:27-33.
    PubMed     Abstract available


    October 2022
  8. KRAUSE D, Richardson DL
    Is there a role for secondary debulking in ovarian cancer? A review of the current literature.
    Curr Opin Obstet Gynecol. 2022 Oct 14. pii: 00001703-990000000-00030.
    PubMed     Abstract available


    February 2021
  9. WASHINGTON CR, Moore KN
    PARP inhibitors in the treatment of ovarian cancer: a review.
    Curr Opin Obstet Gynecol. 2021;33:1-6.
    PubMed     Abstract available


  10. HINCHCLIFF E, Chelariu-Raicu A, Westin SN
    Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance.
    Curr Opin Obstet Gynecol. 2021;33:19-25.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.